Merit Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
5,004
-608
-11% -$41.5K ﹤0.01% 1647
2026
Q1
$363K Buy
+5,612
New +$396K ﹤0.01% 1554
2025
Q4
Sell
-3,289
Closed -$241K 1980
2025
Q3
$241K Buy
+3,289
New +$218K ﹤0.01% 1561

Other funds holding HALO

Merit Financial Group's HALO Position: Q2 2026 in Review

Merit Financial Group reduced its Halozyme (HALO) stake by 11% in Q2 2026, selling an estimated $41.5K and leaving 5,004 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Merit Financial Group first reported a position in HALO in Q3 2025 and has held it in 3 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Merit Financial Group held 5,004 shares of Halozyme worth $392K as of Q2 2026.
  • Merit Financial Group sold 608 Halozyme shares in Q2 2026, an estimated $41.5K.
  • Halozyme made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1647 holding.
  • Merit Financial Group first reported a position in Halozyme in Q3 2025 and has held it in 3 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.